Philips convenes the Annual General Meeting of Shareholders 2024
March 22 2024 - 4:00AM
Philips convenes the Annual General Meeting of Shareholders 2024
March 22, 2024
Amsterdam, the Netherlands – Royal Philips
(NYSE: PHG, AEX: PHIA), today announced it has convened the Annual
General Meeting of Shareholders (AGM) 2024 and published the agenda
with explanatory notes.
As previously announced, the agenda includes:
- Proposals to re-appoint Chairman Feike Sijbesma (Dutch, 1959)
and Peter Löscher (Austrian, 1957) as members of the Supervisory
Board, with effect from May 7, 2024.
- Proposal to appoint Charlotte Hanneman (Dutch, 1978) as member
of the Board of Management, fulfilling the role of Chief Financial
Officer, with effect from October 1, 2024.
- Proposal to appoint Benoît Ribadeau-Dumas (French, 1972) as new
member of the Supervisory Board, with effect from May 7, 2024.
The agenda furthermore includes:
- Proposals to adopt an amended Remuneration Policy for the Board
of Management and an amended Remuneration Policy for the
Supervisory Board.
- A number of recurring items, such as the 2023 Remuneration
Report as included in the Annual Report 2023 (advisory vote), and
the proposals to adopt the company’s financial statements and
dividend.
The AGM will be held at the Hotel Hilton Amsterdam, Apollolaan
138, Amsterdam on Tuesday, May 7, 2024, beginning at 14:00 CET.
The complete agenda with explanatory notes, the Annual Report
2023 (which was published on February 20, 2024), the binding
nominations, the proposed Remuneration Policies and other
information relevant for the AGM have been published here.
For further information, please
contact:
Elco van GroningenPhilips External RelationsTel.: +31 6 8103
9584E-mail: elco.van.groningen@philips.com
Dorin DanuPhilips Investor RelationsTel: +31 20 5977055E-mail:
dorin.danu@philips.com
About Royal PhilipsRoyal Philips (NYSE: PHG,
AEX: PHIA) is a leading health technology company focused on
improving people's health and well-being through meaningful
innovation. Philips’ patient- and people-centric innovation
leverages advanced technology and deep clinical and consumer
insights to deliver personal health solutions for consumers and
professional health solutions for healthcare providers and their
patients in the hospital and the home. Headquartered in the
Netherlands, the company is a leader in diagnostic imaging,
ultrasound, image-guided therapy, monitoring, and enterprise
informatics, as well as in personal health. Philips generated 2023
sales of EUR 18.2 billion and employs approximately 69,700
employees with sales and services in more than 100 countries. News
about Philips can be found at www.philips.com/newscenter.
Forward-looking statementsThis release contains
certain forward-looking statements with respect to the financial
condition, results of operations and business of Philips and
certain of the plans and objectives of Philips with respect to
these items. Examples of forward-looking statements include
statements made about the strategy, estimates of sales growth,
future EBITA, future developments in Philips’ organic business and
the completion of acquisitions and divestments. By their nature,
these statements involve risk and uncertainty because they relate
to future events and circumstances and there are many factors that
could cause actual results and developments to differ materially
from those expressed or implied by these statements.
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From Nov 2024 to Dec 2024
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From Dec 2023 to Dec 2024
